TELA Bio
NASDAQ: TELAMalvern, US · Founded 2012 · Delaware corporation · 5 known investors
Founders & leadership
TELA Bio was founded in 2012 by Antony Koblish.
AK
Antony KoblishFounder
FC
Francis ConwayExecutive
MP
Maarten PersenaireExecutive
CA
Christine ArasinNamed on SEC filing
VB
Vince BurgessNamed on SEC filing
Board
KR
Kevin RakinBoard director
AF
Ashley FreidmanBoard director
AO
AC
Adele C. OlivaBoard director
AF
Ashley FriedmanBoard director
VB
Vince BurgassBoard director
PT
Paul TouheyBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$82.7M disclosed across 10 rounds · 2014–2019
▶$10.6MraisedJul 2019 · 15 investors · BiotechnologyRule 506(b)
▶$10.6MraisedJul 2019 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Antony KoblishExecutive Officer, Director
- Ashley FriedmanDirector
- Matt ZugaDirector
- Kurt AzarbarzinDirector
- Nora BrennanExecutive Officer
- Adele OlivaDirector
- Maarten PersenaireExecutive Officer
- Francis ConwayExecutive Officer
- Ronald J. Ellis, Jr.Director
- Vince BurgessDirector
- Offering amount
- $20M
- Amount sold
- $10.6M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedDec 2018 · 8 investors · BiotechnologyRule 506(b)
▶$2.1MraisedDec 2018 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adele OlivaDirector
- Francis ConwayExecutive Officer
- Kevin RakinDirector
- Ronald J. Ellis, Jr.Director
- Antony KoblishExecutive Officer, Director
- Maarten PersenaireExecutive Officer
- Kurt ArarbarzinDirector
- Ashley FriedmanDirector
- Vince BurgessDirector
- Offering amount
- $3.5M
- Amount sold
- $2.1M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$501.1KraisedMay 2018 · 1 investors · BiotechnologyRule 506(b)
▶$501.1KraisedMay 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adele OlivaDirector
- Maarten PersenaireExecutive Officer
- Antony KoblishExecutive Officer, Director
- Kevin RakinDirector
- Francis ConwayExecutive Officer
- Ronald J. Ellis Jr.Director
- Ashley FriedmanDirector
- Vince BurgessDirector
- Christopher SmithExecutive Officer
- Paul TouheyDirector
- Offering amount
- $2M
- Amount sold
- $501.1K
- Minimum investment
- $250K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$240KraisedMay 2018 · 1 investors · BiotechnologyRule 506(b)
▶$240KraisedMay 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Antony KoblishExecutive Officer, Director
- Ronald J. Ellis, Jr.Director
- Paul TouheyDirector
- Ashley FriedmanDirector
- Maarten PersenaireExecutive Officer
- Francis ConwayExecutive Officer
- Vince BurgessDirector
- Christoper SmithExecutive Officer
- Adele OlivaDirector
- Kevin RakinDirector
- Offering amount
- $240K
- Amount sold
- $240K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedApr 2018 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedApr 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Antony KoblishExecutive Officer, Director
- Ronald J. Ellis, Jr.Director
- Paul TouheyDirector
- Adele OlivaDirector
- Ashley FriedmanDirector
- Christopher SmithExecutive Officer
- Kevin RakinDirector
- Maarten PersenaireExecutive Officer
- Vince BurgessDirector
- Francis ConwayExecutive Officer
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedApr 2018 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedApr 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Maarten PersenaireExecutive Officer
- Christopher SmithExecutive Officer
- Ashley FriedmanDirector
- Ronald J. Ellis, Jr.Director
- Francis ConwayExecutive Officer
- Kevin RakinDirector
- Paul TouheyDirector
- Adele OlivaDirector
- Antony KoblishExecutive Officer, Director
- Vince BurgessDirector
- Offering amount
- $1M
- Amount sold
- $500K
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedNov 2017 · 1 investors · BiotechnologyRule 506(b)
▶$15MraisedNov 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Antony KoblishExecutive Officer, Director
- Kevin RakinDirector
- Christopher SmithExecutive Officer
- Paul TouheyDirector
- Francis ConwayExecutive Officer
- Adele OlivaDirector
- Maarten PersenaireExecutive Officer
- Vince BurgessDirector
- Ashley FriedmanDirector
- Offering amount
- $25M
- Amount sold
- $15M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.4MraisedJan 2017 · 16 investors · BiotechnologyRule 506(b)
▶$7.4MraisedJan 2017 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Vince BurgassDirector
- Kevin RakinDirector
- Ashley FreidmanDirector
- Francis ConwayExecutive Officer
- Maarten PersenaireExecutive Officer
- Antony KoblishExecutive Officer, Director
- Paul TouheyDirector
- Adele OlivaDirector
- Offering amount
- $7.5M
- Amount sold
- $7.4M
- Minimum investment
- $50K
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded TELA Bio?
- TELA Bio was founded by Antony Koblish in 2012.
- Who are TELA Bio's investors?
- TELA Bio's investors include Checkmate Capital Group LLC, Essex Woodlands Healthcare Partners, OrbiMed, Signet Healthcare Partners, 1315 Capital.
- How much funding has TELA Bio raised?
- TELA Bio has disclosed $82.7M raised across 10 rounds.
- Where is TELA Bio headquartered?
- TELA Bio is headquartered in Malvern, US.